MedTrace Logo

Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women

NCT06220747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 760

Last updated 2024-10-09

No results posted yet for this study

Summary

To assess the effectiveness of HPV vaccine 2 doses or less to prevent HPV high risk infection among adolescents and adults. We conduct the test-negative control study including 12-45 women who interest to do a check-up pap smear. Cases were women who met the inclusion criteria and tested positive for HPV DNA, and controls were defined as women who met inclusion criteria but tested negative. For the proposed HPV VE study, we will enroll nine controls for each enrolled case. The participants will be interviewed about their demographics and vaccine histories. Potential confounders data will be collected by interview or self- report questionnaire. HPV DNA test will be done by urine or self-cervical sampling (optional). In case the participant has previous HPV test result within 1 year, the result will be recorded and analysed without repeating the test.

Conditions

Sponsors & Collaborators

  • National Research Council of Thailand

    collaborator OTHER_GOV

  • Mahidol University

    lead OTHER

Principal Investigators

  • Punnee Pitisuttithum, Prof. · Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University

Eligibility

Min Age
12 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-29
Primary Completion
2025-03-31
Completion
2025-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06220747 on ClinicalTrials.gov